Scroll Top

Schwarzer Cardiotek’s EP-TRACER 2 to expand Medtronic’s product offering in atrial fibrillation (afib)

Schwarzer Cardiotek GmbH announced today that it has signed a formal distribution agreement with Medtronic International Trading Sàrl for the sale and distribution of its innovative electrophysiology platform EP-TRACER 2 in Europe, Middle East and Africa.

The non-exclusive distribution agreement will enable Medtronic to market EP-TRACER 2 alongside with its successful product portfolio as a complete diagnosis-to-therapy-solution for the electrophysiology lab. EP-TRACER 2 offers several software features, uniquely designed to improve cryo-ablation procedures.

“The EP-TRACER’s ability to display the cryo-curve in real-time, together with the visualization of the response of phrenic nerve pacing greatly improves comfort and safety during my cryo-ablation procedures”, says Prof Dr Carlo de Asmundis at Universitair Ziekenhuis Brussel, Belgium.

Frank-Peter Klein, President & CEO of Schwarzer Cardiotek adds “Medtronic is a global leader in advanced solutions for afib treatment, we are excited that they have recognized the unique advantages of our technology and the benefits our combined solution will bring to electrophysiologists.”